LD2D.10

ICD-11 MMS 2026-01

Neurofibromatosis type 1

Description

Neurofibromatosis type 1 (NF1) is an inherited, multi-system, neurocutaneous disorder that predisposes to the development of benign and malignant tumours. Two of the following criteria are required to diagnose NF1: six or more café au lait patches, neurofibromas, i.e. peripheral nerve sheath tumours manifesting as cutaneous, sub-cutaneous or plexiform lesions, skin-fold freckling, two or more iris Lisch nodules, an optic pathway glioma, a specific bony dysplasia (thinning of the long bone cortex, sphenoid wing dysplasia), an affected first-degree relative.

Index terms

  • Neurofibromatosis type 1
  • NF1 - [Neurofibromatosis type 1]
  • Neurofibromatosis, peripheral type
Show allHide
  • Recklinghausen disease
  • von Recklinghausen disease
  • von Recklinghausen neuropathy
  • Segmental neurofibromatosis 1
  • Familial spinal neurofibromatosis

Inclusions

  • von Recklinghausen disease

Exclusions from above levels

  • 2E83.Z – Enchondromatosis
  • 4A01.31 – Ataxia-telangiectasia
  • 8C21.1 – familial dysautonomia [Riley-Day]
Show allHide
  • LA90.00 – Rendu-Osler-Weber disease
  • LD23 – Sturge-Weber syndrome
  • LD26.60 – Angio-osteohypertrophic syndrome
  • LD2C – Proteus syndrome
  • LD2F.1Y – Maffucci syndrome
  • http://id.who.int/icd/entity/733825440 – Inborn errors of metabolism

Sibling codes

  • LD2D.11 – Neurofibromatosis type 2
  • LD2D.12 – Neurofibromatosis type 3
  • LD2D.1Y – Other specified neurofibromatoses
  • LD2D.1Z – Neurofibromatosis, unspecified

Foundation entity

Neurofibromatosis type 1 – http://id.who.int/icd/entity/337970533

Part of: LD2D.1: Neurofibromatoses › LD2D: Phakomatoses or hamartoneoplastic syndromes › 20: Developmental anomalies